NeuroMetrix Inc
NASDAQ:NURO
NeuroMetrix Inc
Total Current Liabilities
NeuroMetrix Inc
Total Current Liabilities Peer Comparison
Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
NeuroMetrix Inc
NASDAQ:NURO
|
Total Current Liabilities
$1.8m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-1%
|
|
Boston Scientific Corp
NYSE:BSX
|
Total Current Liabilities
$4.9B
|
CAGR 3-Years
13%
|
CAGR 5-Years
2%
|
CAGR 10-Years
11%
|
|
Stryker Corp
NYSE:SYK
|
Total Current Liabilities
$7B
|
CAGR 3-Years
21%
|
CAGR 5-Years
13%
|
CAGR 10-Years
7%
|
|
Abbott Laboratories
NYSE:ABT
|
Total Current Liabilities
$14B
|
CAGR 3-Years
4%
|
CAGR 5-Years
9%
|
CAGR 10-Years
3%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Total Current Liabilities
$1.4B
|
CAGR 3-Years
15%
|
CAGR 5-Years
13%
|
CAGR 10-Years
12%
|
|
Shockwave Medical Inc
NASDAQ:SWAV
|
Total Current Liabilities
$92.3m
|
CAGR 3-Years
40%
|
CAGR 5-Years
45%
|
CAGR 10-Years
N/A
|
See Also
What is NeuroMetrix Inc's Total Current Liabilities?
Total Current Liabilities
1.8m
USD
Based on the financial report for Mar 31, 2024, NeuroMetrix Inc's Total Current Liabilities amounts to 1.8m USD.
What is NeuroMetrix Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
-1%
Over the last year, the Total Current Liabilities growth was 30%. The average annual Total Current Liabilities growth rates for NeuroMetrix Inc have been -4% over the past three years , -16% over the past five years , and -1% over the past ten years .